Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 17, 2024 -- Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10 in BMJ Open Diabetes Research & Care.
Chan Soon Park, from Seoul National University Hospital in South Korea, and colleagues used data from 8,794 patients with T2DM participating in the U.K. Biobank (2006 to 2010 with follow-up through 2021) to understand the prognostic value of personality (sociability, warmth, diligence, curiosity, and nervousness) and its association with lifestyle factors.
The researchers found that during a median of 13.6 years of follow-up, diligence was significantly associated with a reduced risk for incident CVD. A trend toward lower incidence was seen for the composite outcome (adjusted hazard ratio, 0.93), as well as individual components: myocardial infarction, ischemic stroke, atrial fibrillation, and heart failure. For both high and low diligence, healthy lifestyle behaviors significantly reduced the risk for composite CVDs in groups. A structural equation model showed that diligence directly affected the risk for the primary outcome or indirectly by modifying lifestyle behaviors.
"These findings highlight the importance of assessing personality traits for cardiovascular risk prediction and modifying lifestyle factors as preventive strategies for patients with T2DM," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Self-Esteem Scores Soar One Year After Metabolic, Bariatric Surgery
TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with higher postoperative weight...
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
MONDAY, June 23, 2025 -- For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist...
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 -- For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.